Dr. Harvey Risch, a professor of epidemiology at the Yale School of Public Health, said Tuesday that he believes hydroxychloroquine could save 75,000 to 100,000 lives if the drug is widely used to treat the coronavirus.
“There are many doctors who have received hostile comments from me saying that all the evidence is bad and, in fact, that is not true at all,” Risch told “Ingraham Angle,” adding that he believes the drug can be used. as “prophylactic” for front-line workers, as other countries like India have done.
Risch regretted that a “propaganda war” is being waged against the use of drugs for political purposes, not based on “medical facts.”
OTHERS CALL CHINA TRAVEL BAN XENOPHOBIC, NOW THEY CHANGE THEIR TUNING
Researchers at the Henry Ford Health System in Southeast Michigan found that early administration of hydroxychloroquine makes hospitalized patients much less likely to die.
The study, published in the International Journal of Infectious Diseases, found that hydroxychloroquine provided a “66 percent reduction in risk ratio,” and hydroxychloroquine and azithromycin a 71 percent reduction, compared to none of the treatments. .
Hospital mortality was 18.1 percent overall; 13.5 percent with hydroxychloroquine alone, 22.4 percent with azithromycin alone, and 26.4 percent with none of the medications. “Prospective trials are needed” for further review, the researchers note, even when they concluded: “In this multi-hospital evaluation, when controlling for risk factors for COVID-19, treatment with hydroxychloroquine alone and in combination with azithromycin was associated with a reduction in Mortality associated with COVID-19 “.
CLICK HERE FOR THE FULL MAP OF CORONAVIRUSES
“Our results differ from some other studies,” Dr. Marcus Zervos, who heads the hospital’s infectious disease unit, said at a news conference. “What we think was important in ours … is that patients were treated early. For hydroxychloroquine to have a benefit, it must start before patients begin to experience some of the serious immune reactions that patients may have with COVID “.
A Trump campaign statement hailed the study as “fantastic news.”
CLICK HERE FOR THE FOX NEWS APP
Risch said that most of the mainstream doesn’t allow people to talk about the evidence on the effectiveness of hydroxychloroquine. Risch also said that drug discussions became “political” rather than “medical.”
“All the evidence is really good when used on an outpatient basis. However, the only people who really say that are a lot of doctors who are on the front line treating those patients across the country and are the ones who are at risk of being forced not to, “Risch said, arguing that the leading Media do not cover the benefits of hydroxychloroquine.
